Top compounds associated with response to PDILT


Feature Type Standardized
Nominal ANOVA
mRNA Irinotecan CCLE pan-cancer AAC -0.0016 1
mRNA AZ628 GDSC1000 pan-cancer AAC 0.0015 1
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.00093 1
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.0008 1
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.00075 1
mRNA SB 505124 GDSC1000 pan-cancer AAC -0.0007 1
mRNA Bortezomib gCSI pan-cancer AAC 0.0012 1
mRNA CCT007093 GDSC1000 pan-cancer AAC 0.00062 1
mRNA itraconazole CTRPv2 pan-cancer AAC -0.00062 1
mRNA Axitinib GDSC1000 pan-cancer AAC -0.00051 1
Download CSV